The invention discloses crRNA (Clustered Regularly Interspaced Short Palindromic Repeat-Derived Ribonucleic Acid) for specifically detecting
exon mutation of human
KRAS genes #2 and #3 based on a
CRISPR technique. The crRNA is characterized by comprising a
CRISPR-Cas13a
system as well as crRNA, wherein the crRNA can be combined with the
CRISPR-Cas13a
system; and the crRNA has a sequence format of5'-Cas13a
protein anchoring sequence-crRNA guide sequence-3'. The crRNA has the advantages that according to detection results, whether the human
KRAS gene have
mutation or not can be judged intuitively through fluorescent reading, high-flux sequencing can be avoided, and the crRNA has the advantages of being low in cost, possible in multi-time detection, high in detection speed, possible in direct result analysis, and the like, and is applicable to large-scale clinical sample detection; the
nucleic acid testing technique disclosed by the invention is different from a conventional detection technique which is based on PCR (
Polymerase Chain Reaction) techniques, and no complex
temperature control instrument or
system is needed in a whole reaction process; and three steps of reactions are carried out in a same
reaction system, so that operation procedures can be further simplified, and
nucleic acid fragments with specific sequences can be detected within two hours.